SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-072895
Filing Date
2020-03-13
Accepted
2020-03-13 16:14:36
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d896114ds3.htm S-3 448317
2 EX-1.3 d896114dex13.htm EX-1.3 11894
3 EX-4.4 d896114dex44.htm EX-4.4 341498
4 EX-4.5 d896114dex45.htm EX-4.5 335958
5 EX-4.6 d896114dex46.htm EX-4.6 35106
6 EX-4.7 d896114dex47.htm EX-4.7 35773
7 EX-5.1 d896114dex51.htm EX-5.1 30762
8 EX-23.1 d896114dex231.htm EX-23.1 1989
9 GRAPHIC g896114g0311071519821.jpg GRAPHIC 2016
10 GRAPHIC g896114g0311071520148.jpg GRAPHIC 7169
11 GRAPHIC g896114g60j99.jpg GRAPHIC 73425
  Complete submission text file 0001193125-20-072895.txt   1356622
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237159 | Film No.: 20712831
SIC: 2836 Biological Products, (No Diagnostic Substances)